165 related articles for article (PubMed ID: 37377785)
1. CD4+ and CD8+ cell counts are significantly correlated with absolute lymphocyte count in hospitalized COVID-19 patients: a retrospective study.
Liana P; Samosir AP; Sari NP; Andriani RAL; Verdiansah V; Hidayatullah H; Ahmad Z; Umar TP
PeerJ; 2023; 11():e15509. PubMed ID: 37377785
[TBL] [Abstract][Full Text] [Related]
2. Lymphopenia in Multiple Sclerosis patients treated with Ocrelizumab is associated with an effect on CD8 T cells.
Abbadessa G; Maida E; Miele G; Lavorgna L; Marfia GA; Valentino P; De Martino A; Cavalla P; Bonavita S
Mult Scler Relat Disord; 2022 Apr; 60():103740. PubMed ID: 35305426
[TBL] [Abstract][Full Text] [Related]
3. Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in SARS-CoV-2 infected patients: a single center study.
Iannetta M; Buccisano F; Fraboni D; Malagnino V; Campogiani L; Teti E; Spalliera I; Rossi B; Di Lorenzo A; Palmieri R; Crea A; Zordan M; Vitale P; Voso MT; Andreoni M; Sarmati L
Sci Rep; 2021 Jun; 11(1):12762. PubMed ID: 34140530
[TBL] [Abstract][Full Text] [Related]
4. Significant CD4, CD8, and CD19 lymphopenia in peripheral blood of sarcoidosis patients correlates with severe disease manifestations.
Sweiss NJ; Salloum R; Gandhi S; Alegre ML; Sawaqed R; Badaracco M; Pursell K; Pitrak D; Baughman RP; Moller DR; Garcia JG; Niewold TB
PLoS One; 2010 Feb; 5(2):e9088. PubMed ID: 20140091
[TBL] [Abstract][Full Text] [Related]
5. Thymosin Alpha-1 Has no Beneficial Effect on Restoring CD4+ and CD8+ T Lymphocyte Counts in COVID-19 Patients.
Wang Z; Chen J; Zhu C; Liu L; Qi T; Shen Y; Zhang Y; Xu L; Li T; Qian Z; Steinhart CR; Lu H
Front Immunol; 2021; 12():568789. PubMed ID: 34149679
[TBL] [Abstract][Full Text] [Related]
6. Effects of Short-Term Low-Dose Glucocorticoids for Patients with Mild COVID-19.
Fu HY; Luo Y; Gao JP; Wang L; Li HJ; Li X; Xue L; Tang XQ; Li HW; Du YR
Biomed Res Int; 2020; 2020():2854186. PubMed ID: 33015160
[TBL] [Abstract][Full Text] [Related]
7. Effects of Coronavirus Disease 2019 (COVID-19) on Peripheral Blood Lymphocytes and Their Subsets in Children: Imbalanced CD4
Mahmoudi S; Yaghmaei B; Sharifzadeh Ekbatani M; Pourakbari B; Navaeian A; Parvaneh N; Haghi Ashtiani MT; Mamishi S
Front Pediatr; 2021; 9():643299. PubMed ID: 33937149
[No Abstract] [Full Text] [Related]
8. [Analysis of the correlation between lymphocyte subsets and severity of corona virus disease 19].
Bao F; Shi WL; Hu J; Zhang D; Gao DH; Xia YX; Jing HM; Ke XY; Ge QG; Shen N
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1075-1081. PubMed ID: 33331316
[TBL] [Abstract][Full Text] [Related]
9. Hyperglycemia associated with lymphopenia and disease severity of COVID-19 in type 2 diabetes mellitus.
Cheng Y; Yue L; Wang Z; Zhang J; Xiang G
J Diabetes Complications; 2021 Feb; 35(2):107809. PubMed ID: 33288414
[TBL] [Abstract][Full Text] [Related]
10. The predictive role of lymphocyte subsets and laboratory measurements in COVID-19 disease: a retrospective study.
Wang L; Chen J; Zhao J; Li F; Lu S; Liu P; Liu XH; Huang Q; Wang H; Xu QN; Liu X; Yu S; Liu L; Lu H
Ther Adv Respir Dis; 2021; 15():17534666211049739. PubMed ID: 34632871
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte Subset Counts in COVID-19 Patients: A Meta-Analysis.
Huang W; Berube J; McNamara M; Saksena S; Hartman M; Arshad T; Bornheimer SJ; O'Gorman M
Cytometry A; 2020 Aug; 97(8):772-776. PubMed ID: 32542842
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Short-, Mid-, and Long-Term Effects of Tofacitinib on Lymphocytes in Patients With Rheumatoid Arthritis.
van Vollenhoven R; Lee EB; Strengholt S; Mojcik C; Valdez H; Krishnaswami S; Biswas P; Lazariciu I; Hazra A; Clark JD; Hodge J; Wang L; Choy E
Arthritis Rheumatol; 2019 May; 71(5):685-695. PubMed ID: 30427585
[TBL] [Abstract][Full Text] [Related]
13. Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19.
Liu Y; Liao W; Wan L; Xiang T; Zhang W
Viral Immunol; 2021 Jun; 34(5):330-335. PubMed ID: 32297828
[TBL] [Abstract][Full Text] [Related]
14. Reduced Counts of Various Subsets of Peripheral Blood T Lymphocytes in Patients with Severe Course of COVID-19.
Zhao C; Hu X; Xue Q; Chen L
Bull Exp Biol Med; 2022 Apr; 172(6):721-724. PubMed ID: 35501642
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and predictive value of lower CD4
Wen XS; Jiang D; Gao L; Zhou JZ; Xiao J; Cheng XC; He B; Chen Y; Lei P; Tan XW; Qin S; Zhang DY
BMC Infect Dis; 2021 Jan; 21(1):57. PubMed ID: 33435865
[TBL] [Abstract][Full Text] [Related]
16. Impact of age and gender on lymphocyte subset counts in patients with COVID-19.
Löhr P; Schiele S; Arndt TT; Grützner S; Claus R; Römmele C; Müller G; Schmid C; Dennehy KM; Rank A
Cytometry A; 2023 Feb; 103(2):127-135. PubMed ID: 34125495
[TBL] [Abstract][Full Text] [Related]
17. Specific dynamic variations in the peripheral blood lymphocyte subsets in COVID-19 and severe influenza A patients: a retrospective observational study.
Qian F; Gao G; Song Y; Xu Y; Wang A; Wang S; Hao Y; Chen M; Ma X; Zhao T; Guo X; Chen Z; Zhang F
BMC Infect Dis; 2020 Dec; 20(1):910. PubMed ID: 33261583
[TBL] [Abstract][Full Text] [Related]
18. Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China.
Xu B; Fan CY; Wang AL; Zou YL; Yu YH; He C; Xia WG; Zhang JX; Miao Q
J Infect; 2020 Jul; 81(1):e51-e60. PubMed ID: 32315725
[TBL] [Abstract][Full Text] [Related]
19. Immunophenotyping characteristics and outcome of COVID-19 patients: peripheral blood CD8+T cell as a prognostic biomarker for patients with Nirmatrelvir.
Sun Y; Dian Y; Gao Q; Deng G
Front Immunol; 2023; 14():1227905. PubMed ID: 37799722
[TBL] [Abstract][Full Text] [Related]
20. Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients.
Urra JM; Cabrera CM; Porras L; Ródenas I
Clin Immunol; 2020 Aug; 217():108486. PubMed ID: 32479985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
